Recent policies reflect China’s goal of promoting patients’ access to innovative drugs. Noteworthy policy items include: State Council releases 2019 Work Tasks to Deepen Healthcare Reform Center for Drug Evaluation releases the first real-world evidence application policy in China for public comment National Health Commission initiates pilot programs to develop hospital…
